Showing results (161-170 of 500) with videos related to
Sort By:
Pageof 50
Zhonghua Yi Xue Za Zhi|December 15, 2021
[Comparison of alignment between computer assisted surgery and personal specific instrumentation in total knee arthroplasty]X G Wang, Y Li, Y Z He, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2012
Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killingTae Heung Kang, Barbara Ma, Connie Wang, et al.Human Gene Therapy|July 17, 2008
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.Plos One|December 23, 2014
Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironmentLiwen Song, Ming-Chieh Yang, Jayne Knoff, et al.Expert Opinion on Biological Therapy|August 27, 2005
Immunotherapy for gynaecological malignanciesGeorge Coukos, Jose R Conejo-Garcia, Richard B S Roden, et al.Expert Review of Vaccines|April 6, 2007
Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsShaw-Wei D Tsen, Augustine H Paik, Chien-Fu Hung, et al.Journal of Biomedical Science|November 25, 2010
Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activationChao-Yi Wu, Archana Monie, Xiaowu Pang, et al.American Journal of Obstetrics and Gynecology|April 9, 2008
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesisRobert J Kurman, Kala Visvanathan, Richard Roden, et al.Expert Opinion on Biological Therapy|March 21, 2008
Therapeutic human papillomavirus vaccines: current clinical trials and future directionsChien-Fu Hung, Barbara Ma, Archana Monie, et al.Journal of Virology|September 18, 2001
Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor siteA Lamikanra, Z K Pan, S N Isaacs, et al.Pageof 50